Clinical Trials Directory

Trials / Completed

CompletedNCT03155178

In Vivo Preoperative Skin Preparation Persistence Evaluation

96-hour Antimicrobial Persistence Assessment Following Exposure to Saline and Blotting

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Solventum US LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Evaluate persistent antimicrobial effectiveness of chlorhexidine gluconate containing products on abdominal and inguinal sites following a saline and wipe challenge.

Detailed description

Persistent antimicrobial effectiveness was evaluated by measuring the regrowth of normal skin flora at 48 hours, 72 hours and 96 hours, and the suppression of regrowth relative to post-prep (10-min) at 48 hours, 72 hours and 96 hours.

Conditions

Interventions

TypeNameDescription
DRUG3M CHG/IPA PrepApply topically to intact dry skin (abdominal site) for 30 seconds or moist skin (inguinal site) for 2 minutes.
DRUGChloraPrepApply topically to intact dry skin (abdominal site) for 30 seconds or moist skin (inguinal site) for 2 minutes.

Timeline

Start date
2016-12-05
Primary completion
2017-04-25
Completion
2017-04-25
First posted
2017-05-16
Last updated
2024-10-02
Results posted
2020-02-28

Regulatory

Source: ClinicalTrials.gov record NCT03155178. Inclusion in this directory is not an endorsement.